While the power CRISPR/Cas9* has to achieve targeted mutations in nearly any species is clear, what conclusions can we truly draw about its use in genome editing? Attend our webinar, where we’ll answer this question and more with topics including:
- Is genome editing safe and efficient for human therapy?
- Will CRISPR help us rid the world of mosquitos, or find the cure for AIDS?
- How to best expand research applications using deadCas9 protein?
*CRISPR/Cas9 used under license to granted and pending US and international patents from ERS Genomics Limited.
- Guillaume Pavlovic, PhD, Department Head, Genetic Engineering and Model Validation, PHENOMIN-ICS (Institut Clinique de la Souris)